Gommans J, Hijzen T H, Maes R A, Olivier B
Rudolf Magnus Institute for Neurosciences, Department of Psychopharmacology, Faculty of Farmacy, Utrecht University, The Netherlands.
Life Sci. 1997;61(1):11-9. doi: 10.1016/s0024-3205(97)00352-4.
Rats were trained to discriminate eltoprazine (1-(2,3-dihydro-1,4-benzodioxin-5-yl)-piperazine) (1.0 mg/kg p.o.) from demineralized water in a two lever operant procedure. Eltoprazine generalized to the 5-HT1B receptor agonist anpirtoline (6-chloro-2-[piperidyl-4-thiol]-pyridine hydrochloride), the 5-HT(1A,1B) receptor agonists batoprazine (8-(1-piperazinyl)-2H-1-benzopyran-2-one) and 1-NP (1-(1-naphthyl)piperazine hydrochloride), and to the 5-HT(1B/2C) receptor agonist mCPP (1-(3-chlorophenyl)piperazine dihydrochloride). The 5-HT1A receptor agonist flesinoxan (R(+)-N-[2[4-(2,3-dihydro-2-2-hydroxy-methyl-1,4-benzodioxin-5-yl) -1-piperazinyl]ethyl]-4-fluorobenzoamide) generalized partially and the 5-HT1A receptor antagonist WAY-100635 (N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl) cyclohexanecarboxamide trihydrochloride) failed to antagonize the eltoprazine cue, suggesting that 5-HT1A receptors are of limited importance in the discriminative stimulus properties of eltoprazine. Methiothepin, mCPP, mianserin and alprazolam did not antagonize the eltoprazine cue. The 5-HT(1A,1B,1D) receptor agonist GR46611X (3-[3-(2-dimethylamino-ethyl)-1H-indol-6-yl]-N-(4-methoxy-benzyl)acrylam ide) and the 5-HT(1B,1D) receptor antagonist GR127935T (N-[4-methoxy-3-(4-methyl-1-piperazinyl) phenyl]-2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl) [1,1,-biphenyl]-4-carboxamide) did neither generalize to nor antagonize the eltoprazine cue, whereas (-)-alprenolol showed partial antagonism and substitution. These results show that the eltoprazine discriminative stimulus is mediated by the 5-HT1B receptor, although the lack of good 5-HT1B receptor antagonists weakens this conclusion.
在双杠杆操作性实验程序中,训练大鼠从去离子水中辨别埃托普嗪(1-(2,3-二氢-1,4-苯并二恶英-5-基)-哌嗪)(口服剂量1.0毫克/千克)。埃托普嗪可与5-HT1B受体激动剂安匹托林(6-氯-2-[哌啶基-4-硫醇]-吡啶盐酸盐)、5-HT(1A,1B)受体激动剂巴托普嗪(8-(1-哌嗪基)-2H-1-苯并吡喃-2-酮)和1-NP(1-(1-萘基)哌嗪盐酸盐)以及5-HT(1B/2C)受体激动剂mCPP(1-(3-氯苯基)哌嗪二盐酸盐)产生交叉反应。5-HT1A受体激动剂氟司立生(R(+)-N-[2[4-(2,3-二氢-2-羟基甲基-1,4-苯并二恶英-5-基)-1-哌嗪基]乙基]-4-氟苯甲酰胺)有部分交叉反应,而5-HT1A受体拮抗剂WAY-100635(N-[2-[4-(2-甲氧基苯基)-1-哌嗪基]乙基]-N-(2-吡啶基)环己烷甲酰胺三盐酸盐)未能拮抗埃托普嗪线索,这表明5-HT1A受体在埃托普嗪的辨别刺激特性中重要性有限。甲硫噻平、mCPP、米安色林和阿普唑仑均未拮抗埃托普嗪线索。5-HT(1A,1B,1D)受体激动剂GR46611X(3-[3-(2-二甲基氨基乙基)-1H-吲哚-6-基]-N-(4-甲氧基苄基)丙烯酰胺)和5-HT(1B,1D)受体拮抗剂GR127935T(N-[4-甲氧基-3-(4-甲基-1-哌嗪基)苯基]-2'-甲基-4'-(5-甲基-1,2,4-恶二唑-3-基)[1,1'-联苯]-4-甲酰胺)既不与埃托普嗪线索产生交叉反应也不拮抗该线索,而(-)-阿普洛尔则表现出部分拮抗和替代作用。这些结果表明,埃托普嗪的辨别刺激是由5-HT1B受体介导的,尽管缺乏有效的5-HT1B受体拮抗剂削弱了这一结论。